Overview
Obligated since award on contracts active FY2021–FY2026
Click a company to open its profile.
Insight NATIONAL INSTITUTES OF HEALTH NIAID (75N930) is its largest buyer. See more on the Buyers tab
Agencies report with a delay; the latest year will rise
Hover over a year to see its value.
Insight Largest year: $1.94M in FY2018; since FY2021, $1.63M in FY2022. See more on the Contracts tab
$9.89M since award = $7.49M in FY2021–FY2026 + $2.4M before FY2021
Click a state to open its page.
- Maryland$676K · 6.8%
No US state recorded: $9.22M · 93%
Insight 100% was performed in Maryland. See more on the Contracts tab
Contracts
16 contracts with an action since FY2021
Click a tile to open its contract.
Insight HHSN272201700020I orders hold 86% of these contracts' obligations.
Click a bar to open its industry page.
Insight 82% under NAICS 541711.
Hover over a year to see its value.
Insight 89% of its prime obligations came through HHSN272201700020I orders.
Current end date of each prime contract with an action since FY2021
Hover over a month to see its value.
Pharmacology Discovery Services Taiwan prime contracts with an action in FY2021–FY2026
Find a contract by vehicle, office or end date; sort by money to see the largest.
1 end within 12 months.
Showing 1–10 of 16 contracts
| Since award, US$ | |||||
|---|---|---|---|---|---|
| Parent contract (IDVIDV: the record type for any contract that exists to take orders: IDIQs, GWACs, GSA Schedules, BPAs and basic ordering agreements. Glossary) | ObligatedObligation: money the government has legally committed to a contract. It is not the same as money paid. Example: $6M obligated of a $10M ceiling. Glossary | ||||
| 75N93023F00002 | HHSN272201700020I | NATIONAL INSTITUTES OF HEALTH NIAID (75N930) | $1,239,019 | Feb 7, 2025 | Ended |
| 75N93022F00003 | HHSN272201700020I | NATIONAL INSTITUTES OF HEALTH NIAID (75N930) | $1,197,620 | Aug 11, 2023 | Ended |
| 75N93021F00002 | HHSN272201700020I | NATIONAL INSTITUTES OF HEALTH NIAID (75N930) | $952,930 | Aug 9, 2022 | Ended |
| 75N93020F00159 | HHSN272201700020I | NATIONAL INSTITUTES OF HEALTH NIAID (75N930) | $933,804 | Jul 31, 2021 | Ended |
| 75N93021F00003 | HHSN272201700020I | NATIONAL INSTITUTES OF HEALTH NIAID (75N930) | $680,842 | Jul 30, 2023 | Ended |
| 75N93019F00131 | HHSN272201700020I | NATIONAL INSTITUTES OF HEALTH NIAID (75N930) | $652,380 | Jun 30, 2020 | Ended |
| 75N93026F00002 | 75N93024D00017 | NATIONAL INSTITUTES OF HEALTH NIAID (75N930) | $621,336 | Jul 14, 2031 | Running |
| 75N93023F00001 | HHSN272201700020I | NATIONAL INSTITUTES OF HEALTH NIAID (75N930) | $599,260 | Feb 27, 2025 | Ended |
| 75N93026F00003 | 75N93024D00017 | NATIONAL INSTITUTES OF HEALTH NIAID (75N930) | $545,542 | Sep 29, 2027 | Ends within 12 months |
| 75N93018F00003 | HHSN272201700020I | NATIONAL INSTITUTES OF HEALTH NIAID (75N930) | $506,429 | Aug 15, 2023 | Ended |
Buyers
National Institutes of Health: $9.89M obligated since award; $6.15M in FY2021–FY2025 actions
Click a bar to open its office page.
Insight National Institutes of Health placed 100%.
Contracting offices that awarded its prime contracts, FY2021–FY2026
See which offices award its contracts.
0 offices awarded only one contract.
Showing 1–1 of 1 office
| Contracts active FY2021–FY2026; obligated since award, US$ | |||||
|---|---|---|---|---|---|
| NATIONAL INSTITUTES OF HEALTH NIAID (75N930) | National Institutes of Health | 16 | $9,890,968 | Jun 5, 2018 | Sep 30, 2026 |
Opportunities
Open opportunities matching Pharmacology Discovery Services Taiwan's registered industries
Notices in its 1 industry (NAICSNAICS code: a six-digit code for the kind of work a company does. Each contract carries one, and it sets the small-business size limit. Glossary): 325412
9 of the next 10 are due within 30 days.
Showing 1–10 of 10 opportunities
| Opportunity | Agency | Due |
|---|---|---|
| 6505--Sodium Bicarbonate Injection Vial Restricted to Made in America (opens in Procura)Presolicitation · NAICS 325412Free account: full notice, dates, attachments Contacts · paid plans | Department of Veterans AffairsNAC PHARMACEUTICALS (36E797) | Oct 21, 2026 |
| Inhaled Nitric Oxide (opens in Procura)Sources Sought · NAICS 325412Free account: full notice, dates, attachments Contacts · paid plans | Defense Health Agency (DOD)DEFENSE HEALTH AGENCY (HT9408) | Oct 22, 2026 |
| Methylphenidate ER (opens in Procura)Solicitation · NAICS 325412Free account: full notice, dates, attachments Contacts · paid plans | Defense Logistics Agency (DOD)DLA TROOP SUPPORT (SPE2D2) | Oct 23, 2026 |
| Department of War Pharmacy Uniform Formulary Blanket Purchase Agreement / Uniform Formulary Additional Discount Program (opens in Procura)Solicitation · NAICS 325412Free account: full notice, dates, attachments Contacts · paid plans | Defense Health Agency (DOD)DEFENSE HEALTH AGENCY (DHA) (HT0040) | Oct 26, 2026 |
| 6505--Imatinib Tablets (opens in Procura)Solicitation · NAICS 325412Free account: full notice, dates, attachments Contacts · paid plans | Department of Veterans AffairsNAC PHARMACEUTICALS (36E797) | Oct 30, 2026 |
| 6505--FY27 Low Energy General Radiopharmaceuticals 36C25027Q0052 (opens in Procura)Sources Sought · NAICS 325412Free account: full notice, dates, attachments Contacts · paid plans | Department of Veterans Affairs250-NETWORK CONTRACT OFFICE 10 (36C250) | Nov 3, 2026 |
| LIDOCAINE 5% PATCHES-REQUEST FOR INFORMATION (opens in Procura)Sources Sought · NAICS 325412Free account: full notice, dates, attachments Contacts · paid plans | Department of Veterans AffairsNATIONAL CMOP OFFICE (36C770) | Nov 3, 2026 |
| Epinephrine Injector (opens in Procura)Solicitation · NAICS 325412Free account: full notice, dates, attachments Contacts · paid plans | Defense Logistics Agency (DOD)DLA TROOP SUPPORT (SPE2D2) | Nov 16, 2026 |
| 6505--Department of Veterans Affairs Pharmaceutical Industry Day (opens in Procura)Special Notice · NAICS 325412Free account: full notice, dates, attachments Contacts · paid plans | Department of Veterans AffairsNAC FEDERAL SUPPLY SCHEDULE (36F797) | Nov 20, 2026 |
| TECHNOLOGY LICENSING OPPORTUNITY: Clathrate Therapeutics Platform (opens in Procura)Special Notice · NAICS 325412Free account: full notice, dates, attachments Contacts · paid plans | Department of EnergyOffice 899015 | Dec 4, 2026 |
Registration and contacts
Registration
- UEI
- MXP1NVQ8C1J8
- CAGE code
- SCSX7
- Registration
- Active, expires Dec 3, 2026
- Entity type
- Corporate Entity (Not Tax Exempt)
- Location
- New Taipei City, 248
Registered industries (NAICSNAICS code: a six-digit code for the kind of work a company does. Each contract carries one, and it sets the small-business size limit. Glossary)
Registered in 1 industry; primary 325412
- 325412 Pharmaceutical Preparation ManufacturingPrimary
Contacts at Pharmacology Discovery Services Taiwan, Ltd.
| Contact | Role | As of |
|---|---|---|
| See contactsLocked · 7-day trial or paid plan (name, title and contact details with a 7-day trial or paid plan) | Government business POC · Electronic business POCSAM.gov registrationAs of Dec 3, 2025 | Dec 3, 2025 |
| See contactsLocked · 7-day trial or paid plan (name, title and contact details with a 7-day trial or paid plan) | Alternate electronic business POCSAM.gov registrationAs of Dec 3, 2025 | Dec 3, 2025 |
Correct this listing
Tell us what to correct or add on the Pharmacology Discovery Services Taiwan, Ltd. page. We check every request before we change a profile.